Novel treatment targets for COVID-19: Contribution from molecular psychiatry

World J Biol Psychiatry. 2020 Sep;21(7):572-575. doi: 10.1080/15622975.2020.1779344. Epub 2020 Jul 3.

Authors

Ulrike Schmidt^{1

2}, Theo Rein³

Affiliations

¹ Klinik für Psychiatrie und Psychotherapie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
² Klinik für Psychiatrie und Psychotherapie, Georg-August Universität Göttingen, Göttingen, Germany.
³ Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.

PMID: 32619139
DOI: 10.1080/15622975.2020.1779344

No abstract available

Publication types

Letter

MeSH terms

Biological Psychiatry / methods
Brain Diseases / etiology
Brain Diseases / therapy*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / therapy*
Humans
Molecular Biology / methods
Nervous System Diseases / etiology
Nervous System Diseases / therapy*
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / therapy*